Dopamine (DA) is an important and prototypical slow neurotransmitter in the mammalian brain, where it controls a variety of functions including locomotor activity, motivation and reward, learning and memory, and endocrine regulation. Once released from presynaptic axonal terminals, DA interacts with at least five receptor subtypes in the central nervous system (CNS), which have been divided into two groups: the D1-like receptors (D1Rs), comprising D1 and D5 receptors, both positively coupled to adenylyl cyclase and cAMP production, and the D2-like receptors (D2Rs), comprising D2, D3, and D4 receptors, whose activation results in inhibition of adenylyl cyclase and suppression of cAMP production. In addition, D1Rs and D2Rs modulate intracellular Ca2+ levels and a number of Ca2+ -dependent intracellular signaling processes. Through diverse cAMP- and Ca2+-dependent and - independent mechanisms, DA influences neuronal activity, synaptic plasticity, and behavior. Presynaptically localized D2Rs regulate synthesis and release of DA as the main autoreceptor of the dopaminergic system.

Organismal Systems; Nervous system
BRITE hierarchy

PMID:21303898

Beaulieu JM, Gainetdinov RR

The physiology, signaling, and pharmacology of dopamine receptors.

Pharmacol Rev 63:182-217 (2011)
DOI:10.1124/pr.110.002642

PMID:15521361

Neve KA, Seamans JK, Trantham-Davidson H

Dopamine receptor signaling.

J Recept Signal Transduct Res 24:165-205 (2004)
DOI:10.1081/RRS-200029981

PMID:17408758

Surmeier DJ, Ding J, Day M, Wang Z, Shen W

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Trends Neurosci 30:228-35 (2007)
DOI:10.1016/j.tins.2007.03.008

PMID:20224735

Knab AM, Lightfoot JT

Does the difference between physically active and couch potato lie in the dopamine system?

Int J Biol Sci 6:133-50 (2010)
DOI:10.7150/ijbs.6.133

PMID:10433257

Greengard P, Allen PB, Nairn AC

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.

Neuron 23:435-47 (1999)
DOI:10.1016/S0896-6273(00)80798-9

PMID:15590733

Hu XT, Dong Y, Zhang XF, White FJ

Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.

J Neurophysiol 93:1406-17 (2005)
DOI:10.1152/jn.00771.2004

PMID:17349698

Beaulieu JM, Gainetdinov RR, Caron MG

The Akt-GSK-3 signaling cascade in the actions of dopamine.

Trends Pharmacol Sci 28:166-72 (2007)
DOI:10.1016/j.tips.2007.02.006

PMID:19138563

De Mei C, Ramos M, Iitaka C, Borrelli E

Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.

Curr Opin Pharmacol 9:53-8 (2009)
DOI:10.1016/j.coph.2008.12.002

PMID:15381316

Seamans JK, Yang CR

The principal features and mechanisms of dopamine modulation in the prefrontal cortex.

Prog Neurobiol 74:1-58 (2004)
DOI:10.1016/j.pneurobio.2004.05.006

PMID:18353279

Yao WD, Spealman RD, Zhang J

Dopaminergic signaling in dendritic spines.

Biochem Pharmacol 75:2055-69 (2008)
DOI:10.1016/j.bcp.2008.01.018

PMID:20727368

Li YC, Gao WJ

GSK-3beta activity and hyperdopamine-dependent behaviors.

Neurosci Biobehav Rev 35:645-54 (2011)
DOI:10.1016/j.neubiorev.2010.08.001

PMID:15292232

Tang TS, Bezprozvanny I

Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.

J Biol Chem 279:42082-94 (2004)
DOI:10.1074/jbc.M407389200

PMID:12967774

Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS

Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.

Trends Pharmacol Sci 24:486-92 (2003)
DOI:10.1016/S0165-6147(03)00232-3

PMID:9457173

Missale C, Nash SR, Robinson SW, Jaber M, Caron MG

Dopamine receptors: from structure to function.

Physiol Rev 78:189-225 (1998)
DOI:10.1152/physrev.1998.78.1.189

PMID:19251795

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ

Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?

Eur Respir J 33:468-80 (2009)
DOI:10.1183/09031936.00056908